Getinge AB
STO:GETI B

Watchlist Manager
Getinge AB Logo
Getinge AB
STO:GETI B
Watchlist
Price: 179.6 SEK 0.62% Market Closed
Market Cap: 48.9B SEK
Have any thoughts about
Getinge AB?
Write Note

Net Margin
Getinge AB

5%
Current
9%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5%
=
Net Income
1.7B
/
Revenue
33.6B

Net Margin Across Competitors

Country SE
Market Cap 48.9B SEK
Net Margin
5%
Country US
Market Cap 199.7B USD
Net Margin
14%
Country US
Market Cap 190.4B USD
Net Margin
29%
Country US
Market Cap 140.1B USD
Net Margin
16%
Country US
Market Cap 133.8B USD
Net Margin
11%
Country IE
Market Cap 103.7B USD
Net Margin
13%
Country US
Market Cap 66.2B USD
Net Margin
9%
Country DE
Market Cap 58.2B EUR
Net Margin
8%
Country US
Market Cap 44.6B USD
Net Margin
74%
Country CN
Market Cap 313.1B CNY
Net Margin
33%
Country US
Market Cap 36.2B USD
Net Margin
9%
No Stocks Found

Getinge AB
Glance View

Market Cap
48.9B SEK
Industry
Health Care

Getinge AB, rooted in the lush landscapes of Sweden, has steadily evolved into a global leader in the medical technology sector. The company began its journey by manufacturing traditional sterilizers over a century ago. Over time, Getinge has carefully navigated and adapted to the ever-changing dynamics of the healthcare industry, positioning itself squarely at the intersection of innovation and practicality. Today, Getinge specializes in a broad spectrum of medical equipment and systems, focusing on critical care, surgery, and infection prevention. This focus is intricately designed to cater to hospitals and healthcare facilities worldwide, ensuring that patients receive the highest standard of care during complex procedures and critical conditions. Revenue streams for Getinge are as diversified as its product portfolio, comprising equipment sales, service contracts, and consumables. The company’s product offerings range from sophisticated ventilators and state-of-the-art heart-lung machines, to efficient sterilization and surgical workflow products. Beyond simply selling devices, Getinge builds sustainable revenue through long-term service agreements and the sale of replacement parts and consumables, which are essential for the ongoing, optimal operation of its technologically advanced machinery. This strategic emphasis on combining cutting-edge product development with a robust support infrastructure underscores Getinge’s business model, ensuring loyalty and ongoing relationships with healthcare institutions globally.

GETI B Intrinsic Value
282.94 SEK
Undervaluation 37%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5%
=
Net Income
1.7B
/
Revenue
33.6B
What is the Net Margin of Getinge AB?

Based on Getinge AB's most recent financial statements, the company has Net Margin of 5%.